|
|
||||||||
Ann Thorac Surg 2005;79:283
© 2005 The Society of Thoracic Surgeons
Department of Thoracic and Cardiovascular Surgery, Kansai Medical University, 10-15 Fumizonocho, Moriguchi 570-8507, Japan
| The first 20% of the full text of this article appears below. |
Pulmonary metastasectomy has become a widely accepted surgical treatment for a patient with metastatic lung tumor. In the study by Shiono and colleagues, the overall 5-year survival rate of the patients who underwent pulmonary metastasectomy seems to be extremely high compared with the survival rates reported by several authors previously. After 5 years, however, the survival curve in this study decreased, to less than 40% at 84 months. Presumably, an excellent 5-year survival rate would be a reflection of a length bias caused by the biological behavior of the metastatic pulmonary lesions.
In this paper, Shiono and associates did not identify any clinical factors, including preoperative
Related Article
Ann. Thorac. Surg. 2005 79: 278-282.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |